OVERLAND PARK, Ks., September 2, 2020 – George Clinical, a global scientifically-backed clinical research organization, has expanded the organization’s team in China with the addition of Dr. Zhenfei Yin in the role of Country Head and Regional Head of Project Operations. Zhenfei will be responsible for leading operations teams across China. Zhenfei brings nearly a […]
Read MoreOVERLAND PARK, Ks., August 18, 2020 – Alta Schutte, Ph.D., an expert researcher in hypertension and cardiovascular disease has joined George Clinical, a global scientifically-backed clinical research organization, as a member of the organization’s scientific leadership team. Schutte serves as Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine in the faculty of medicine at […]
Read MoreSimon Finfer, professorial fellow in the Critical Care and Trauma Division at The George Institute, was recently appointed an Officer of the Order of Australia (General Division) in the Queen’s Birthday Honors list. Dr. Finfer, a critical care physician, has been working with The George Institute for 20 years and during that time has led […]
Read MoreOVERLAND PARK, Ks., June 24, 2020 – George Clinical, a global scientifically-backed clinical research organization, is pleased to announce that Dr. Adrian Liew, a national leader in Singapore and steering committee member for various global clinical trials in nephrology has joined the scientific leadership team at George Clinical. Dr. Liew is a Senior Consultant Nephrologist […]
Read MoreThere is an urgent need to raise awareness among rural women and healthcare workers at all levels of the postpartum period and the long-term health of women with a history of hypertension and gestational diabetes mellitus (GDM). Early identification and counseling of women at high risk of cardiometabolic disorders through innovative community-level interventions may offer […]
Read MoreOVERLAND PARK, Ks., April 30, 2020 – George Clinical, a global scientifically-backed clinical research organization, is collaborating with Saint Luke’s Mid America Heart Institute on a new study which will explore whether dapagliflozin (an SGLT inhibitor) can prevent disease progression in patients hospitalized with COVID-19 and at high risk for complications due to pre-existing cardio […]
Read MoreSYDNEY, April 2, 2020 – George Clinical, a global scientifically-backed clinical research organization, is leveraging the organization’s significant health and medical expertise, operational infrastructure and data science teams to actively advise stakeholders on potential COVID-19 vaccine and treatment studies. The organization has also taken significant steps over the past few months to ensure that the […]
Read MoreWomen are more likely to survive a stroke, but have a worse disability and poorer quality of life afterward compared to men, according to research published in the latest issue of Neurology®, the medical journal of the American Academy of Neurology. The George Institute for Global Health researchers looked at sex differences in treatment and […]
Read MoreGeorge Clinical has been recognized by PharmaTech Outlook, an industry trade journal, in the annual listing of the top 10 companies operating in the Asia-Pacific region that are at the forefront of providing clinical trial consulting services and transforming businesses. The Top 10 Clinical Trial Management recognition is timely given George Clinical expansion in multiple […]
Read MoreGeorge Clinical Scientific Leader Dr. Lee Schwartzberg has been named among the Best Doctors in America List published by Teladoc. Schwartzberg, based in Memphis, TN, is a member of the scientific leadership team with an oncology focus. Harvard Medical School physicians founded Best Doctors in 1989 as a global benefits provider and medical information services […]
Read More
